Allergan Inc. (AGN) R&D Innovations Recognized With Three Nominations For The 2014 U.S. Prix Galien Awards
8/4/2014 11:40:48 AM
IRVINE, Calif.--(BUSINESS WIRE)--Allergan, Inc. (NYSE: AGN) (“Allergan” or the “Company”) today announced that the Company’s research and development pipeline has been recognized by the Galien Foundation, which has nominated three of Allergan’s products for the 2014 U.S. Prix Galien Awards. The Prix Galien Award is considered the biomedical industry’s highest accolade and recognizes the technical, scientific and clinical research skills necessary to develop innovative medicines and devices.
Help employers find you! Check out all the jobs and post your resume.
comments powered by